Skip to main content
Published locations for Idarucizumab given the nod as the first specific antidote for an oral anticoagulant
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Idarucizumab given the nod as the first specific antidote for an oral anticoagulant
User login
Username
Password
Reset your password
/content/idarucizumab-given-nod-first-specific-antidote-oral-anticoagulant
/jcso/article/106046/patient-survivor-care/idarucizumab-given-nod-first-specific-antidote-oral
/hematology-oncology/article/106046/patient-survivor-care/idarucizumab-given-nod-first-specific